Cargando…
Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum
Cryptosporidiosis is an intestinal disease that affects a variety of hosts including animals and humans. Since no vaccines exist against the disease till date, drug treatment is the mainstay of disease control. Nitazoxanide (NTZ) is the only FDA-approved drug for the treatment of human cryptosporidi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227457/ https://www.ncbi.nlm.nih.gov/pubmed/35745507 http://dx.doi.org/10.3390/pathogens11060653 |
_version_ | 1784734182141853696 |
---|---|
author | Nguyen-Ho-Bao, Tran Ambe, Lum A. Berberich, Maxi Hermosilla, Carlos Taubert, Anja Daugschies, Arwid Kamena, Faustin |
author_facet | Nguyen-Ho-Bao, Tran Ambe, Lum A. Berberich, Maxi Hermosilla, Carlos Taubert, Anja Daugschies, Arwid Kamena, Faustin |
author_sort | Nguyen-Ho-Bao, Tran |
collection | PubMed |
description | Cryptosporidiosis is an intestinal disease that affects a variety of hosts including animals and humans. Since no vaccines exist against the disease till date, drug treatment is the mainstay of disease control. Nitazoxanide (NTZ) is the only FDA-approved drug for the treatment of human cryptosporidiosis. However, its efficacy in immunocompromised people such as those with AIDS, in malnourished children, or those with concomitant cryptosporidiosis is limited. In the absence of effective drugs against cryptosporidiosis, improving the efficacy of existing drugs may offer an attractive alternative. In the present work, we have assessed the potential of the cell-penetrating peptide (CPP) octaarginine (R8) to increase the uptake of NTZ. Octaarginine (R8) was synthetically attached to NTZ in an enzymatically releasable manner and used to inhibit growth of Cryptosporidium parvum in an in vitro culture system using human ileocecal adenocarcinoma (HCT-8) cell line. We observed a significant concentration-dependent increase in drug efficacy. We conclude that coupling of octaarginine to NTZ is beneficial for drug activity and it represents an attractive strategy to widen the repertoire of anti-cryptosporidial therapeutics. Further investigations such as in vivo studies with the conjugate drug will help to further characterize this strategy for the treatment of cryptosporidiosis. |
format | Online Article Text |
id | pubmed-9227457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92274572022-06-25 Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum Nguyen-Ho-Bao, Tran Ambe, Lum A. Berberich, Maxi Hermosilla, Carlos Taubert, Anja Daugschies, Arwid Kamena, Faustin Pathogens Article Cryptosporidiosis is an intestinal disease that affects a variety of hosts including animals and humans. Since no vaccines exist against the disease till date, drug treatment is the mainstay of disease control. Nitazoxanide (NTZ) is the only FDA-approved drug for the treatment of human cryptosporidiosis. However, its efficacy in immunocompromised people such as those with AIDS, in malnourished children, or those with concomitant cryptosporidiosis is limited. In the absence of effective drugs against cryptosporidiosis, improving the efficacy of existing drugs may offer an attractive alternative. In the present work, we have assessed the potential of the cell-penetrating peptide (CPP) octaarginine (R8) to increase the uptake of NTZ. Octaarginine (R8) was synthetically attached to NTZ in an enzymatically releasable manner and used to inhibit growth of Cryptosporidium parvum in an in vitro culture system using human ileocecal adenocarcinoma (HCT-8) cell line. We observed a significant concentration-dependent increase in drug efficacy. We conclude that coupling of octaarginine to NTZ is beneficial for drug activity and it represents an attractive strategy to widen the repertoire of anti-cryptosporidial therapeutics. Further investigations such as in vivo studies with the conjugate drug will help to further characterize this strategy for the treatment of cryptosporidiosis. MDPI 2022-06-06 /pmc/articles/PMC9227457/ /pubmed/35745507 http://dx.doi.org/10.3390/pathogens11060653 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nguyen-Ho-Bao, Tran Ambe, Lum A. Berberich, Maxi Hermosilla, Carlos Taubert, Anja Daugschies, Arwid Kamena, Faustin Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum |
title | Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum |
title_full | Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum |
title_fullStr | Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum |
title_full_unstemmed | Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum |
title_short | Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum |
title_sort | octaarginine improves the efficacy of nitazoxanide against cryptosporidium parvum |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227457/ https://www.ncbi.nlm.nih.gov/pubmed/35745507 http://dx.doi.org/10.3390/pathogens11060653 |
work_keys_str_mv | AT nguyenhobaotran octaarginineimprovestheefficacyofnitazoxanideagainstcryptosporidiumparvum AT ambeluma octaarginineimprovestheefficacyofnitazoxanideagainstcryptosporidiumparvum AT berberichmaxi octaarginineimprovestheefficacyofnitazoxanideagainstcryptosporidiumparvum AT hermosillacarlos octaarginineimprovestheefficacyofnitazoxanideagainstcryptosporidiumparvum AT taubertanja octaarginineimprovestheefficacyofnitazoxanideagainstcryptosporidiumparvum AT daugschiesarwid octaarginineimprovestheefficacyofnitazoxanideagainstcryptosporidiumparvum AT kamenafaustin octaarginineimprovestheefficacyofnitazoxanideagainstcryptosporidiumparvum |